ACHE and Alzheimer disease: Today, AD treatment is mainly aimed at increasing the level of the neurotransmitter acetylcholine by inhibiting acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), the enzymes responsible for acetylcholine’s hydrolysis.